Generation and Correction of iPSCs with MAPT Mutation
Corresponding Organization :
Other organizations : Washington University in St. Louis, Neural Stem Cell Institute, Hope Center for Neurological Disorders
Variable analysis
- Transduction of dermal fibroblasts from MAPT p.R406W carriers with non-integrating Sendai virus carrying OCT3/4, SOX2, KLF4, and cMYC
- CRISPR/Cas9 editing of iPSCs heterozygous for MAPT p.R406W to wild-type (WT)
- Generation of induced pluripotent stem cells (iPSCs) from dermal fibroblasts
- Cell lines were maintained in mTeSR medium on Matrigel
- Cell lines were confirmed to be free of mycoplasma
- Positive control: Dermal fibroblasts from MAPT p.R406W carriers (F11362 and F11421)
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!